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Impaired autophagy bridges lysosomal storage
disease and epithelial dysfunction in the kidney
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The endolysosomal system sustains the reabsorptive activity of specialized epithelial cells.
Lysosomal storage diseases such as nephropathic cystinosis cause a major dysfunction of
epithelial cells lining the kidney tubule, resulting in massive losses of vital solutes in the urine.
The mechanisms linking lysosomal defects and epithelial dysfunction remain unknown,
preventing the development of disease-modifying therapies. Here we demonstrate, by
combining genetic and pharmacologic approaches, that lysosomal dysfunction in cystinosis
results in defective autophagy-mediated clearance of damaged mitochondria. This promotes
the generation of oxidative stress that stimulates Gα12/Src-mediated phosphorylation of
tight junction ZO-1 and triggers a signaling cascade involving ZO-1-associated Y-box factor
ZONAB, which leads to cell proliferation and transport defects. Correction of the primary
lysosomal defect, neutralization of mitochondrial oxidative stress, and blockage of tight
junction-associated ZONAB signaling rescue the epithelial function. We suggest a link
between defective lysosome-autophagy degradation pathways and epithelial dysfunction,
providing new therapeutic perspectives for lysosomal storage disorders.
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The epithelial cells lining the proximal tubules (PT) of thekidney constitute a paradigm of effective communicationbetween the environment and endomembrane compart-
ments, allowing the reabsorption of essential nutrients. By pro-
cessing incoming substances and recycling receptors and
transporters at the apical plasma membrane, the endolysosomal
system dictates cell differentiation, hence the maintenance of
homeostasis1,2. The PT uptake accounts for ~ 80% of the clear-
ance of small proteins and peptides, which are continuously ﬁl-
tered and completely reabsorbed by apical endocytosis involving
the multi-ligand receptors, megalin, and cubilin3. Alterations in
these transport processes lead to generalized PT dysfunction (an
entity named renal Fanconi syndrome, RFS), causing urinary loss
of solutes and low-molecular-weight (LMW) proteins, often
complicated by dehydration, electrolyte imbalance, rickets,
growth retardation, and development of chronic kidney disease
(CKD). Such PT dysfunctions are typically encountered in con-
genital disorders due to defective endolysosomal transporters,
particularly in nephropathic cystinosis4.
Cystinosis is a lysosomal storage disease (LSD) caused by
recessive, inactivating mutations in the CTNS gene coding for the
proton-driven transporter cystinosin that exports cystine out of
lysosomes5. The loss of cystinosin causes an accumulation of
cystine in tissues, leading to renal failure, diabetes, hypothyr-
oidism, myopathy, and central nervous system deterioration.
Infantile (MIM #219800) and juvenile (MIM #219900) forms of
cystinosis represent a frequent cause of congenital PT dysfunction
and RFS, most often complicated by CKD6. The only available
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Fig. 1 Abnormal lysosome dynamics and autophagy in CTNS-deﬁcient PT cells. a Left: confocal microscopy and three-dimensional (3D) reconstruction of
Ctns mPTCs labeled with anti-LAMP1 (red) antibody. Right: quantiﬁcation of changes in vesicle size (top, each point representing the average size of
LAMP1+ vesicles in a cell) and lysosome positioning (bottom, percent of perinuclear or peripheral distribution) (n= 30 cells pooled from 3 Ctns kidneys per
group; two-tailed unpaired t-test, #P< 0.0001 relative to Ctns+/+ mPTCs). b–f Ctns mPTCs were cultured in normal growth (Fed; 8 h) or nutrient-deprived
cell medium (Starved; 8 h). b Representative confocal micrographs (left) and quantiﬁcation (right) of numbers of LC3+ structures (green) in Ctns mPTCs
(n= 100 cells pooled from three Ctns kidneys per group; each point representing the number of LC3+ vesicles in a cell; one-way analysis of variance
(ANOVA) followed by Bonferroni’s posthoc test, ***P< 0.001 relative to Ctns+/+ mPTCs under fed conditions; NS, not signiﬁcant.). cWestern blotting and
densitometric analyses of LC3 protein levels. β-Actin was used as a loading control. Two-tailed unpaired Student’s t-test, *P< 0.05 relative to Ctns+/+
mPTCs under fed conditions, n= 3 independent experiments. d Representative electron micrographs (left) and quantiﬁcation (right) of numbers of
autophagic vacuoles per cell (n= 10 micrographs per each condition; one-way ANOVA followed by Bonferroni’s posthoc test, **P< 0.01 and #P< 0.0001
relative to Ctns+/+ mPTCs under fed conditions; NS, not signiﬁcant). e Representative confocal micrographs and quantiﬁcation of SQSTM1+ structures
(red) in CtnsmPTCs (n= 100 cells pooled from three Ctns kidneys per group; two-tailed unpaired Student’s t-test, #P< 0.0001 relative to Ctns+/+ mPTCs).
f Representative western blotting of SQSTM1 in CtnsmPTCs. GAPDH was used as a loading control, n= 3 independent experiments. Plotted data represent
mean± SEM. Nuclei are counterstained with DAPI (blue). Scale bars are 10 μm in a, b, and e, and 2 μm in d. Unprocessed scans of original blots are shown
in Supplementary Fig. 13
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strategy to counteract cystine storage is oral administration of
cysteamine, which allows cystine to exit lysosomes. However,
cysteamine treatment is hampered by side effects and poor tol-
erance, and it does not treat nor prevent PT dysfunction6,7. Thus,
there is an urgent need to identify novel therapeutic strategies for
this devastating disorder. Recent studies based on a Ctns mouse
model that recapitulates multiple features of cystinosis8 have
demonstrated that the loss of cystinosin is associated with aber-
rations of the endolysosomal compartment, and abnormal pro-
liferation and dysfunction of PT cells9. Despite the identiﬁcation
of cellular defects associated with cystinosis in different models
and cell systems10, a unifying mechanism linking loss of cysti-
nosin, lysosomal dysfunction, and defective epithelial transport
has not been deciphered.
In most mammalian cells, the endolysosomal system captures
and degrades intracellular worn-out constituents through
autophagy11. This homeostatic process is particularly active in
PT cells, whose intense reabsorptive and transport properties
require the maintenance of mitochondrial network12. The
autophagy-mediated turnover of damaged mitochondria is
required for protecting PT from acute tubular injury13, whereas
deletion of essential autophagy genes damages PT cells through
defective mitochondrial clearance and increased reactive oxygen
species (ROS)14. Of note, accumulation of distorted mitochon-
dria15 and of autophagy receptor SQSTM1/p62 has been descri-
bed in kidney biopsies and urinary cells from cystinotic
patients16, suggesting a possible involvement of autophagy. In
addition, recent evidences show that cystinosin is a component of
the lysosomal mammalian target of rapamycin complex1
(mTORC1)17, a hub that regulates autophagy-lysosome func-
tions18 and nutrient transport in renal epithelial cells19. Alto-
gether, these data suggest potential interactions between
cystinosin function, the autophagy–lysosome degradation path-
ways, and the transport properties in PT epithelial cells.
In the present study, we decipher a pathway linking loss-of-
function of cystinosin, lysosome–autophagy dysfunctions, mito-
chondrial oxidative stress, disruption of tight junction integrity,
and activation of a signaling cascade causing epithelial cell
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Fig. 2 Cystinosin deﬁciency alters autophagy in proximal tubules of mouse and zebraﬁsh kidneys. a Representative confocal micrographs and quantiﬁcation
of numbers of LC3+ (left panel; red) or SQSTM1+ structures (right panel; red) in LTL+ (green) proximal tubules in Ctns mouse kidneys (n= 30 proximal
tubules pooled from three kidneys per group; each point representing the number of LC3+ or SQSTM1+ vesicles in a proximal tubule; two-tailed unpaired
Student’s t-test, ***P< 0.001 relative to Ctns+/+kidneys). Nuclei counterstained with DAPI (blue). b Western blotting and densitometric analyses of LC3
protein levels in whole kidney lysates from Ctns mice (two-tailed unpaired Student’s t-test, *P= 0.029 relative to Ctns+/+ kidneys, n= 3 mice per group). c
Representative images of ctns+/+ and ctnsdel8/del8 zebraﬁsh embryos at 5 dpf and d quantiﬁcation of cystine levels by HPLC in ctns+/+ and ctns del8/del8
zebraﬁsh embryos at 5 dpf (two-tailed unpaired Student’s t-test,***P< 0.001 relative to ctns+/+embryos, n= 8 ctns+/+ zebraﬁsh and n= 7 ctns del8/del8
zebraﬁsh). e Western blotting and densitometric analyses of LC3 protein levels in pronephric tubules from 3-month-old ctns+/+ and ctns del8/del8 zebraﬁsh
(n= 4 per group; two-tailed unpaired Student’s t-test, *P= 0.03 relative to ctns+/+ kidneys). f Representative electron micrographs and quantiﬁcation of
numbers and size of autophagic vacuoles in pronephric tubules of ctns+/+ and ctnsdel8/del8 zebraﬁsh embryos at 5 dpf. White squares contain images at
higher magniﬁcation. Yellow arrowhead indicates autophagic vacuoles. Number of autophagic vesicles: n= 43 (ctns+/+) and n= 42 (ctnsdel8/del8) randomly
selected micrographs were pooled from 11 ctns+/+ and 12 ctnsdel8/del8 zebraﬁsh. Average vesicle size: n= 32 (ctns+/+) and n= 33 (ctnsdel8/del8) randomly
selected micrographs were pooled from 11 ctns+/+ and 12 ctnsdel8/del8 zebraﬁsh. Two-tailed unpaired Student’s t-test, ***P< 0.001 and #P< 0.0001 relative
to ctns+/+ zebraﬁsh. β-Actin was used as a loading control in b and e. Plotted data represent mean± SEM. Scale bars are 50 μm in a and 5 μm in f
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-02536-7 ARTICLE
NATURE COMMUNICATIONS |  (2018) 9:161 |DOI: 10.1038/s41467-017-02536-7 |www.nature.com/naturecommunications 3
dysfunction and loss of transport capacity. These insights offer
new therapeutic strategies for treating epithelial dysfunction in
nephropathic cystinosis and endolysosomal disorders.
Results
Loss of cystinosin alters lysosomal dynamics and autophagy.
We ﬁrst investigated the consequences of Ctns deletion on the
lysosomal–autophagy pathways in epithelial cells. The loss of
cystinosin, which was reﬂected by the accumulation of cystine in
mouse kidneys and derived PT cells (mPTCs), induced a phe-
notype switch associating abnormal proliferation and apical
dedifferentiation, leading to defective receptor-mediated endo-
cytosis and urinary loss of LMW proteins in vivo (Supplementary
Fig. 1a–g). These changes, which conﬁrmed the validity of the
Ctns mouse model and derived mPTCs8,9, were associated with a
dramatic modiﬁcation in lysosomal dynamics as evidenced by
enlarged lysosomes, clustered into the perinuclear region (Fig. 1a
and Supplementary Movies 1–2).
As the intracellular positioning of lysosomes coordinates
autophagy in response to nutrient availability20, we tested whether
the perinuclear clustering of lysosomes reﬂects changes in
autophagy. We used mPTCs, because this primary culture system
provides a particularly suited model to decipher the molecular
mechanisms underpinning the endolysosome disorders within
epithelial cells21,22. Autophagy was assessed by quantifying the
conversion of the non-lipidated form of LC3-I to the lipidated,
autophagosome-associated form LC3-II, and the numbers of LC3
vesicles23 in mPTCs cultured in nutrient-rich media (hereafter
referred to as “fed”) or in nutrient-deprived conditions (hereafter
referred to as “starved”). Compared with wild-type cells, Ctns−/−
cells showed higher numbers of punctate LC3 structures and steady-
state levels of LC3-II, which did not further increase in starved
conditions (Fig. 1b, c), as well as more electron microscopy (EM)
structures compatible with autophagic vacuoles (Fig. 1d). Likewise,
Ctns−/− cells showed larger numbers of aggregates positive for the
autophagy receptor SQSTM1 (Fig. 1e) and higher SQSTM1 protein
levels, which did not further increase in starved conditions (Fig. 1f).
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Fig. 3 Cystinosin deﬁciency delays the clearance of autophagosomes by impairing lysosome function. a Western blotting and densitometric analyses for
LC3 and SQSTM1 protein levels in Ctns mPTCs cultured in fed or starved medium in the presence or in the absence of 250 nM BfnA1 for 4 h (n= 3
independent experiments). Two-tailed unpaired Student’s t-test, **P< 0.01 (SQSTM1) and *P< 0.05 (LC3) relative to fed Ctns+/+ mPTCs, and *P= 0.05
(SQSTM1) and **P= 0.009 (LC3) relative to starved Ctns+/+ mPTCs. b Correlative light-electron microscopy (CLEM) in Ctns mPTCs co-transduced with
RFP-tagged Lamp1 (LAMP1/RFP, red) GFP-tagged Map1lc3b (Map1lc3b/GFP, green) bearing adenoviral particles for 2 days. The colocalization of GFP-LC3
and RFP-LAMP1 was monitored by confocal microscopy. Selected cells were further processed and serial sections analysed by electron microscopy. Dotted
black squares contain images at higher magniﬁcation. Scale bars are 2 μm (top panel) and 500 nm (bottom panel). c Western blotting and densitometric
analyses of CtsD protein levels in CtnsmPTCs; two-tailed unpaired Student’s t-test, **P< 0.01 relative to Ctns+/+mPTCs, n= 3 independent experiments. d
Ctns mPTCs were loaded with Bodipy-FL-PepA (1 μM, for 1 h at 37 °C, green), immunostained with anti- LAMP1 antibody (red) and analysed by confocal
microscopy. Quantiﬁcation of numbers of PepA/LAMP1+ structures (in percentage of total lysosomes; n= 5 randomly selected ﬁelds per condition, with
each containing ~ 20–25 cells; two-tailed unpaired Student’s t-test, #P< 0.0001 relative to Ctns+/+ mPTCs). e ctns zebraﬁsh embryos expressing cdh17::
GFP (green, pronephric tubule marker) were injected at 5 dpf with Cy5-tagged-β-lactoglobulin. At 120min after the injection of the tracer, zebraﬁsh
embryos were imaged using light sheet ﬂuorescent microscopy. A similar rate of internalization of Cy5-tagged-β-lactoglobulin was observed at 20min in
both ctns+/+ and ctnsdel8/del8 zebraﬁsh embryos, validating the uptake of the tracer by pronephric tubules. Representative micrographs (left) and
quantiﬁcation (right) of numbers of β-lactoglobulin+ structures (red) in ctns zebraﬁsh pronephric tubule (n= 6 zebraﬁsh per group; two-tailed unpaired
Student’s t-test, **P= 0.01 relative to ctns+/+ zebraﬁsh). GAPDH was used as loading control in a and c. Plotted data represent mean± SEM. Nuclei are
counterstained with DAPI (blue). Yellow indicates colocalization. Scale bars are 10 μm in d and 50 μm in e
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The accumulation of LC3-marking autophagosomes and
SQSTM1-positive aggregates was consistently detected in the
PT of Ctns−/− kidneys (Fig. 2a, b). To further explore the
consequences of cystinosin deletion in vivo, we established a
novel ctns knockout zebraﬁsh model using the TALENs
(transcription activator-like effector nucleases) technique (Sup-
plementary Fig. 2a–c). One mutant zebraﬁsh line showed an 8 bp
TALEN-driven deletion (ctnsdel8/del8), resulting in a premature
stop codon within exon 3 of ctns, which would result in a
truncated protein deprived of the transmembrane domains of
cystinosin. Microinjection of wild-type (but not mutant) human
CTNS messenger RNA decreased the cystine storage in ctns-
deﬁcient embryos to the same extent than cysteamine treatment
(Supplementary Fig. 2d). The protein levels of LC3-II and the
numbers of autophagic vesicles (AVs) were remarkably increased
in cystine-accumulating pronephric tubules in ctns-deﬁcient
zebraﬁsh (Fig. 2c–f), demonstrating the evolutionary conservation
of this connection. These results demonstrate that the deletion of
cystinosin alters lysosomal dynamics and autophagy in PT cells,
both in vitro and in vivo.
Cystinosin deﬁciency perturbs autophagic clearance in
PT cells. An increased number of AVs may arise from stimula-
tion of autophagosome biogenesis or from alteration of their
degradation by lysosomes. To discriminate between these two
possibilities, we treated Ctns mPTCs with Baﬁlomycin A1
(BfnA1), a proton pump inhibitor that prevents lysosome
degradation and thus increases autophagic cargoes and substrates
exclusively when autophagy is active23. Treatment with BfnA1
heightened the amounts of LC3-II and SQSTM1 in nutrient-
deprived Ctns+/+ cells, whereas it did not change the already
elevated levels of these proteins in nutrient-deprived Ctns−/− cells
(Fig. 3a).
We next performed a pulse-chase assay to monitor the
degradation of resting autophagosomes in Ctns mPTCs. Cells
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Null. c Quantiﬁcation of changes in the number of CtsD+ and d in the average vesicle size in cells from a (n= 30 cells pooled from three Ctns kidneys per
condition; each point representing the number or the average size of CtsD+ vesicles in a cell; one-way ANOVA followed by Bonferroni’s post hoc test, #P<
0.0001 relative to Ctns+/+ mPTCs or to HA− Ctns−/− mPTCs. e CtnsmPTCs were loaded with MR-CtsB peptide (1 μM, for 1 h at 37 °C) and immunostained
with anti-HA antibody. Quantiﬁcation of numbers of MR-CtsB+ structures (n= 33 cells pooled from three Ctns kidneys per condition, each point
representing the number of MR-CtsB+ vesicles in a cell; one-way ANOVA followed by Bonferroni post hoc test, #P< 0.0001 relative to Ctns+/+mPTCs or to
HA− Ctns−/− mPTCs). f Ctns mPTCs were cultured in fed or starved medium in presence or in absence of 250 nM BfnA1 for 4 h. The cells were lysed and
subjected to western blotting analysis for the protein levels of HA, CtsD, SQSTM1, and LC3. α-Tubulin was used as a loading control, n= 3 independent
experiments. Plotted data represent mean± SEM. The nuclei are counterstained with DAPI (blue). Yellow indicates colocalization. Scale bars are 10 μm
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were starved to form autophagosomes and then treated with the
class III phosphoinositide 3-kinase (PI3K) vacuolar protein
sorting 34 (Vps34) kinase inhibitor SAR-40524 to prevent the
formation of new autophagosomes. We validated the selectivity of
SAR-405 by determining the intracellular phosphatidylinositol-3-
phosphate pools (PtdIns-3P, the end-product generated by Vps34
kinase activity) in mPTCs (Supplementary Fig. 3a). The
degradation of the formed autophagosomes following SAR-405
treatment was tracked by time-lapse confocal microscopy: in
contrast to the autophagic-mediated degradation observed in
starved Ctns+/+ cells, the Ctns−/− cells retained almost all the
formed autophagosomes (Supplementary Fig. 3b, c). Upstream
events regulating autophagosome biogenesis, such as conjugation
(ATG7) and phagosome formation (ATG16L + vesicles), includ-
ing Beclin1, remained unchanged in control and Ctns−/− PT cells
(Supplementary Fig. 4a–c). Taken together, these results indicate
that the accumulation of autophagosomes in Ctns−/− cells results
predominantly from a slower autophagosome clearance rather
than augmented biogenesis.
Defective lysosomal function impedes autophagy in Ctns−/−
cells. A blockade in LC3-II degradation can occur at any step after
autophagosome formation and can be induced by delayed traf-
ﬁcking of autophagosomes to lysosomes and/or reduced fusion
between both compartments25. We thus explored whether the
delayed autophagosome clearance in Ctns−/− cells might be
caused by an impaired autophagosome delivery to lysosomes. To
test this hypothesis, we examined the subcellular distribution of
LC3-marking autophagic structures and LAMP1-labeled lyso-
somes in response to short incubations with non-saturating
d
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concentrations of BfnA1 (50 nM for 1 h)26. Confocal microscopy
analysis showed that cystinosin deletion did not decrease the
colocalization of LC3 and LAMP1-labeled lysosomes in BfnA1-
treated PT cells but rather increased the number of large LAMP1
+ vesicles ﬁlled by LC3 in Ctns−/− PT cells (Supplementary
Fig. 5a). Electron tomography microscopy and three-dimensional
(3D) reconstructed tomograms conﬁrmed the existence of
enlarged, single-membrane structures engulfed with partially
digested cellular debris in Ctns−/− cells (Supplementary Fig. 5b
and Supplementary Movie 3). Accumulation of autophagic
material in autolysosomes of Ctns−/− cells was also conﬁrmed by
correlative light-EM, where GFP-LC3-positive autophagosome
containing cellular constituents coalesced within enlarged, single-
membrane RFP-LAMP1-positive organelles (Fig. 3b), indicating
that the transport and/or autophagosome-lysosome fusion are not
compromised.
One mechanism by which the autophagic cargo clearance
might be impeded is defective lysosomal degradation capacity11.
To substantiate the delayed autophagosome degradation in
Ctns−/− cells, we analyzed trafﬁcking, processing, and maturation
of lysosomal cathepsins. Western blot analyses of cathepsin-D
(CtsD) showed a decreased proteolytic generation of the 32 kDa
mature CtsD in Ctns−/− compared with Ctns+/+cells (Fig. 3c). We
next tested the lysosomal CtsD activity by incubating mPTCs
with Bodipy-FL-PepstatinA (PepA), a ﬂuorescence-tagged PepA
that binds to the active site of CtsD in acidic lysosomes22.
Although the majority of lysosomes were co-stained with PepA-
labeled CtsD in Ctns+/+cells, the number of PepA-labeled vesicles
and the colocalization of active CtsD with LAMP1 were
substantially lower in Ctns−/− cells (Fig. 3d). These changes in
lysosome function were observed despite normal trafﬁcking of
CtsD between Golgi and LAMP1 compartments (Supplementary
a
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Fig. 5c, d). Similarly, the lysosome-based processing of the LMW
β-lactoglobulin, which is normally internalized and degraded by
PT endolysosomes2,3, was dramatically reduced in pronephric
tubules of ctnsdel8/del8 compared with ctns+/+ zebraﬁsh (Fig. 3e).
The key role of cystinosin depletion in lysosomal–autophagy
dysfunctions was assessed by transducing Ctns−/− cells with an
adenovirus that expresses mouse hemagglutinin (HA)-tagged
cystinosin (Ad-Ctns-HA; Fig. 4). The functional re-expression of
HA-CTNS protein at late endosomal/lysosomal compartments in
Ctns−/− cells (Fig. 4a; Supplementary Fig. 6) lowered the
intracellular cystine content (Fig. 4b), rescued the lysosomal
dynamics (Fig. 4c, d), activated cathepsin-B within lysosomes
(Fig. 4e), and augmented the lysosome-mediated degradation of
autophagy substrates SQSTM1 and LC3-II (Fig. 4f) when
compared with Ctns−/− cells transduced with an empty vector.
These features were abolished by treating the HA-CTNS
expressing Ctns−/− cells with BfnA1 (Fig. 4f), indicating that
cystinosin deﬁciency blocks autophagosome clearance by com-
promising lysosome function.
Disruption of autophagy causes epithelial cell dysfunction. As
autophagy mediates cellular homeostasis, we tested whether and
how its disruption may cause epithelial dysfunction. Inactivation
of basal autophagy was obtained by transducing mPTCs with an
adenovirus expressing a short hairpin RNA (Ad-shRNA) against
Atg7 or by inhibiting the autophagy Beclin1/Vps-34 complex with
SAR-405 or Spautin-1.
We conﬁrmed that either shRNA-mediated knockdown of
Atg7 (Fig. 5a) or autophagy inhibitors (Supplementary Fig. 7a–b)
prevented the conversion of LC3-I to LC3-II and increased the
levels of the SQSTM1 protein, and of aggregate-forming SQSTM1
and ubiquitin-positive inclusions (Fig. 5a–c and Supplementary
Fig. 7c) in mPTCs. Disruption of autophagy led to the
accumulation of dysfunctional mitochondria, as shown by
increased levels of prohibitin (an inner mitochondrial membrane
protein; Fig. 5d) and decreased resting mitochondrial membrane
potential (Δψm, assessed by quantitative confocal imaging of
tetramethylrhodamine methyl ester (TMRM) dye; Fig. 5e and
Supplementary Fig. 7d), and the induction of a major
mitochondrial oxidative stress, as scored by elevated mtROS
levels (MitoSOX; Fig. 5f and Supplementary Fig. 7e).
Importantly, either the genetic or the pharmacological
impairment of autophagy induced the nuclear translocation of
tight-junction ZO-1-associated Y-box factor ZONAB (Fig. 5g)
and its activity (as measured by the regulation of the Ccdn1, Pcna,
and Lrp2 targets27,28 (Fig. 5h and Supplementary Fig. 7f). These
changes were reﬂected by a phenotype switch that included
abnormal cell proliferation, as evidenced by bromodeoxyuridine
(BrdU) incorporation (Fig. 5i and Supplementary Fig. 7g), and
dedifferentiation, as testiﬁed by reduced expression of the apical
endocytic receptor megalin (Fig. 5h and Supplementary Fig. 7f)
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and by decreased endocytic uptake (Fig. 5j and Supplementary
Fig. 7h). Collectively, these data demonstrate that the main-
tenance of mitochondrial function and homeostasis by autophagy
is required for the terminal differentiation, hence regulating the
reabsorptive capacity of PT epithelial cells.
Dysfunctional mitochondria drive oxidative stress in Ctns−/−
cells. Having established that disruption of autophagy recapitu-
lates the phenotype switch of proliferation dedifferentiation, we
investigated how defective lysosomal degradation of autophagy
substrates might lead to epithelial dysfunction in cystinosis.
As autophagy delivers protein aggregates and organelles to
endolysosome for cellular degradation, we analyzed the ability of
Ctns−/− mPTCs to clear polyubiquitinated aggregates and
compromised mitochondria. Correlating with the stalled autop-
hagy ﬂux, we found an accumulation of ubiquitin-forming
aggregates and abnormal mitochondria with disorganized cristae
in Ctns−/− compared with Ctns+/+ cells (Fig. 6a–c). The defective
mitochondria in Ctns−/− cells were retained within enlarged,
dysfunctional lysosomes (Fig. 6d) and showed a major decrease in
Δψm (Fig. 6e). Seahorse metabolic ﬂux analyses measuring the
overall consumption rates (OCRs) conﬁrmed markedly decreased
mitochondrial bioenergetics (baseline respiration, ATP turnover,
and total respiratory capacity) in Ctns−/− compared with Ctns+/+
mPTCs (Fig. 6f). These changes were paralleled by a major
mitochondrial oxidative stress, as scored by the elevated mtROS
levels (MitoSOX; Fig. 6g) and increased anti-oxidant response
(heme oxygenase-1 (HO1); Fig. 6h). Overall, these ﬁndings
indicate that impaired lysosome-mediated autophagic degrada-
tion of dysfunctional mitochondria causes a major oxidative
stress in cystinosin-deﬁcient cells.
Abnormal tight junction signaling leads to epithelial dys-
function. Oxidative stress has been shown to induce the
SU
66
56
M
T
SU
66
56
M
T
SU
66
56
M
T
20
40
60
80
100
0%
 N
uc
le
ar
 Z
O
NA
B
20
40
60
80
100
0%
 N
uc
le
ar
 P
CN
A
#
#
#
100
150
200
250
50
0
ZONAB
/DAPI PCNA/DAPI
Al647-BSA/
DAPIZONAB
#
#
#
f g h
#
#
#
BS
A+
 s
tru
ct
ur
es
(nu
mb
er 
pe
r c
ell
)
a
+– –MT
Gα12
pTyr416
c-Src
c-Src
37
75
50
75
50
37
kDa
Ctn
s+
/+
Ctn
s–
/–
β-Actin
pTyr416
c-Src
c
37
75
50
75
50
37
Rotenone +– kDa
Gα12
c-Src
β-Actin
Gα12
pTyr416
c-Src
c-Src
b
37
75
50
75
50
50
Ad-Gna12 shRNA
Ad-Scmb shRNA ++ –
+– –
Ctn
s+
/+
Ctn
s–
/–
kDa
α-Tubulin
pTyr416
c-Src
d
75
37
75
50
75
50
50
ATG7
Gα12
Ad-Scmb shRNA
Ad-Atg7 shRNA
+ –
+– kDa
c-Src
α-Tubulin
Ad-Gna12 shRNA
MT
SU6656
–
–
–
–
–
–
+
–
–
–
+
–
–
–
+ 250
150
100
75
50
37
25
20
15
kDa
250
150
37IB: GAPDH
IP
: Z
O
-1 IB
: p
-T
yr
e
Ctn
s+
/+
Ctn
s–
/–
IB: ZO-1
Ct
ns
+
/+
Ct
ns
+
/+
Ct
ns
+
/+
Ctns+/+
Ctns–/–
Ctns+/+
Ctns–/–
Ctns+/+
Ctns–/–
Ct
ns
–
/–
Ct
ns
–
/–
Ct
ns
–
/–
SU
66
56 MT
SU
66
56 MT
SU
66
56 MT
Fig. 8 Mitochondrial ROS triggers Ga12/Src-mediated destabilization of ZO-1. a Representative western blotting of Gα12, pTyr416 c-Src, and c-Src protein
levels in Ctns mPTCs treated with or without the mitochondria-targeted antioxidant Mito-TEMPO (MT, 10 μM for 24 h). β-Actin was used as a loading
control, n= 3 independent experiments. b Representative western blotting of Gα12, pTyr416 c-Src, and c-Src protein levels in Ctns mPTC transduced with
either Scmb or Gna12 adenoviral shRNAs for 5 days. α-Tubulin used as a loading control, n= 2 independent experiments. c Representative western blotting
of Gα12, pTyr416 c-Src, and c-Src protein levels in mPTCs treated with Rotenone (250 nM for 8 h) or d transduced with Scmb or Atg7 adenoviral shRNAs
for 5 days. In c and d, β-Actin and α-Tubulin were used as a loading control, n= 3 independent experiments. e Tight junction ZO-1 protein was
immunoprecipitated from Ctns+/+ or Ctns−/− mPTCs and from Ctns−/− mPTCs transduced with Ad-Gna12 shRNA or treated with either mitochondria-
targeted antioxidant Mito-Tempo (MT, 10 μM for 24 h) or with a selective Src-kinase inhibitor SU6656 (5 μM for 24 h) and the phosphorylation rate was
examined by western blotting. f–h Ctns mPTCs were treated with either mitochondria-targeted antioxidant MitoTempo (MT, 10 μM for 24 h) or a selective
Src-kinase inhibitor SU6656 (5 μM for 24 h). f Ctns mPTCs were immunostained with anti-ZONAB (green) antibody and imaged by confocal microscopy.
Quantiﬁcation of ZONAB+ nuclei (in percentage of the total nuclei) was obtained from ﬁve randomly selected ﬁelds per condition, with each containing ~
20–25 cells. g Ctns mPTCs were immunostained with anti-PCNA antibody and imaged by confocal microscopy. Quantiﬁcation of PCNA+ nuclei (in
percentage of the total nuclei) obtained from ﬁve randomly selected ﬁelds per condition, with each containing ~ 20–25 cells. h The cells were loaded with
Al647-BSA (50 μg ml−1 for 15 min at 37 °C) and imaged by confocal microscopy. Quantiﬁcation of numbers of Al647-BSA+ structures (n= 100 cells pooled
from three mouse kidneys per condition; each point representing the number of BSA+ structures in a cell). One-way ANOVA followed by Bonferroni’s post
hoc test, #P< 0.0001 relative to Ctns+/+ mPTCs or to untreated Ctns−/− mPTCs. Plotted data are mean± SEM. The nuclei are counterstained with DAPI
(blue). The scale bars are 10 μm
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phosphorylation of the zona occludens-1 (ZO-1) adaptor protein,
disrupting the integrity of the tight junction complex29. As ZO-1
traps the Y-box transcription factor ZONAB that is known to
regulate the differentiation of PT cells27,28, an overproduction of
ROS by dysfunctional mitochondria might alter tight junction
integrity and trigger ZONAB-mediated signaling.
To test this hypothesis, we immunoprecipitated ZO-1 from
mPTCs and noted that it was more heavily phosphorylated in
Ctns−/− vs. Ctns+/+ cells (Fig. 7a). This result was supported by
the proximity ligation assay (PLA) revealing an increased
cytoplasmic phosphorylation of ZO-1 in Ctns−/− cells (Fig. 7b).
ZO-1, which is normally located at cell membrane boundaries as
shown in Ctns+/+ cells, was found to be misrouted and trapped
within LAMP1-positive compartments in Ctns−/− cells (Fig. 7c).
Consistent with the loss of integrity of tight junctions, there was a
nuclear translocation of ZONAB (Fig. 7d) with subsequent
increase in its transcriptional targets Ccdn1, Pcna, and Lrp2
(Fig. 7e). These changes in Ctns−/− cells were coupled to
increased proliferation, as evidenced by measuring cell growth
curves (Fig. 7f) or by the nuclear enrichment of PCNA (Fig. 7h
and Supplementary Fig. 1e), contrasting with decreased receptor-
mediated endocytosis of albumin (Fig. 7i and Supplementary
Fig. 1f).
The link between defective autophagy, compromised mito-
chondria, and oxidative stress was substantiated by the increased
phosphorylation rate of ZO-1 induced by the shRNA-mediated
knockdown of Atg7 in mPTCs (Supplementary Fig. 8a) or by the
treatment of the cells with autophagy inhibitors (SAR-405 and
Spautin-1; Supplementary Fig. 8b), with H2O2 (Supplementary
Fig. 8c) or with the mitochondrial complex I inhibitor Rotenone
(ROT)-stimulating mitochondrial ROS (Supplementary Fig. 8d,e).
Treatment with ROT induced ZONAB translocation and
signaling (Supplementary Fig. 8f, g), reﬂected by increased
proliferation (Supplementary Fig. 8h) and decreased endocytic
uptake (Supplementary Fig. 8i).
The relevance of the abnormal tight junction signaling in
cystinosis was conﬁrmed by gain- and loss-of-function experi-
ments in mPTCs. shRNA-mediated knockdown of Csda encoding
ZONAB (Fig. 7g–i and Supplementary Fig. 9a–c) or over-
expression of exogenous TJP1 encoding ZO-1 (Supplementary
Fig. 9d, e), which functionally inhibits ZONAB27,28, signiﬁcantly
decreased the proliferation markers and rescued the endocytic
uptake in Ctns−/− cells. Conversely, depletion of ZO-1 (shRNA-
mediated knockdown of Tjp1; Supplementary Fig. 10a–c) or
overexpression of Csda (Supplementary Fig. 10d) triggered the
activation of ZONAB signaling (Supplementary Fig. 10e) with
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increased cell proliferation and decreased endocytic uptake of
albumin (Supplementary Fig. 10f) in wild-type cells.
Mitochondrial ROS disrupt tight junctions through Gα12 /Src
activation. Finally, we investigated how aberrant mitochondria-
producing ROS disrupt tight junctions in cystinosis epithelial
cells. Given the accumulation of abnormal mitochondria-
producing ROS (Fig. 6) and higher phosphorylation rate of
ZO-1 (Fig. 7) in Ctns−/− PT cells, we hypothesized that high
levels of mitochondrial ROS may stimulate the Gα12 protein that
triggers the disruption of tight junctions through Src-mediated
phosphorylation of ZO-129–31. This would in turn activate
ZONAB signaling and drives the epithelial dysfunction.
Consistent with this hypothesis, mPTCs from Ctns−/− kidneys
(Fig. 8a, b) displayed an increased protein abundance of Gα12
and activated Src tyrosine kinase (monitored by the increased
phosphorylation of pTyr416-Src; Fig. 8a, b). Likewise, wild-type
mPTCs treated with ROT (Fig. 8c) or accumulating aberrant
mitochondria-producing ROS (shRNA-mediated knockdown of
Atg7; Fig. 8d) also exhibited an abnormal activation of Gα12/Src.
This activation paralleled the increased phosphorylation of ZO-1,
tight junction disruption, and epithelial dysfunction described
above (Fig. 5 and Supplementary Fig. 8).
Having veriﬁed that the high level of mitochondrial ROS drives
epithelial dysfunction by activating Gα12/Src kinase pathway, we
tested whether the neutralization of mitochondrial ROS/Gα12/Src
signaling loop may avert the loss of tight junction integrity and
rescue the function of cystinosis cells. We incubated Ctns−/−
mPTCs with mitochondria-localized-oxygen scavenger Mito-
TEMPO (MT, 10 μM for 24 h; Supplementary Fig. 11a, b32) or
with a selective c-Src family kinase inhibitor SU6656 (5 μM
for 24 h33), or transduced the cells with Ad-shRNA against
Gna12.
The blockage of the mitochondrial ROS/Gα12/Src signaling
cascade by these pharmacologic or genetic interventions reversed
the abnormal activation of Gα12/Src (Fig. 8a, b), preventing the
phosphorylation of ZO-1 (Fig. 8e and Supplementary Fig. 11c)
and its lysosomal accumulation, which increased ZO-1 abun-
dance at cell boundaries (Supplementary Fig. 11d). In turn, these
changes inhibited the nuclear translocation of ZONAB (Fig. 8f)
and restored the differentiation and endocytic uptake of albumin
in cystinosis cells (Fig. 8g, h). Of note, the rescue induced by MT
treatment was prevented by overexpressing Csda-HA in Ctns−/−
mPTCs (Supplementary Fig. 12a, b), supporting the role of
ZONAB.
Taken together, these data suggest that the excess of
mitochondrial ROS, resulting from impaired lysosome-mediated
autophagic degradation of damaged mitochondria, triggers Gα12/
Src-mediated phosphorylation of ZO-1, which disrupts tight
junction integrity and activates ZONAB signaling, causing
epithelial dysfunction in cystinosis cells.
Neutralizing mitochondrial ROS improves epithelial function
in cystinosis. To enhance the translational potential of these
ﬁndings, we administered MT (1 mg kg−1 body weight) to 16-
week-old Ctns mice by daily intraperitoneal injections (Fig. 9a).
After 30 days of treatment, mPTCs were isolated from the Ctns
−/− kidneys to score the epithelial function by measuring the
endocytic uptake of albumin. Treatment with MT effectively
reduced ROS production and oxidative stress (Fig. 9b, c), lowered
levels of the kidney injury marker lipocalin-2 (LCN234) (Fig. 9c),
abrogated abnormal cell proliferation (Fig. 9d) and restored
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abundance of endocytic receptor megalin (LRP2; Fig. 9e),
reﬂected by a signiﬁcant recovery of the ligand uptake (Fig. 9f) in
Ctns−/− cells. Thus, modulation of mitochondrial oxidative stress
ameliorates epithelial function in nephropathic cystinosis.
Discussion
The endolysosomal system regulates the transport activity of
specialized epithelial cells, sustaining their role in homeostasis.
Congenital defects in lysosomal transporters, as exempliﬁed by
cystinosis, cause PT dysfunction and RFS. By combining genetic
and pharmacologic approaches in vitro and in vivo, we decipher
the link between lysosomal disease and epithelial dysfunction in
cystinosis. We demonstrate that lysosomal dysfunction results in
defective autophagy-mediated clearance of damaged
mitochondria-producing ROS, disruption of tight junction
integrity, and activation of a signaling pathway causing epithelial
cell proliferation and dedifferentiation, with loss of reabsorptive
capacity (Fig. 10). These data reveal the fundamental importance
of the lysosome-mediated autophagic clearance in maintaining
epithelial differentiation and offer novel therapeutic perspectives
to restore epithelial transport capacity downstream of the primary
lysosomal defect.
Cystinosin deﬁciency induces a major alteration in lysosomal
dynamics9,35,36, paralleled by increased numbers of autophago-
somes in the PT cells of Ctns−/− mice. Similarly, abnormal
lysosomes and LC3-marking autophagosomes heighten in
cystine-accumulating pronephric tubules in ctns-deﬁcient zebra-
ﬁsh, demonstrating the evolutionary conservation of this con-
nection across vertebrates. Contrasting with cystine storage and
defective lysosome–autophagy pathways, the ctns zebraﬁsh larvae
appear morphologically normal and display neither obvious
development defects nor signs of PT dysfunction. As cystinosis is
typically a storage disease, longitudinal studies are needed to
provide a more comprehensive characterization of the phenotype
after 5 days post fertilization (dpf) in this model.
The accumulation of the autophagy substrate SQSTM1, which
is normally degraded within autolysosomes, suggests an abnormal
autophagy ﬂux in cystinosin-deﬁcient PT cells, in line with recent
observations stating an impairment of autophagy ﬂux in many
lysosome storage diseases37,38 and evidence in human cells and
kidney biopsies from cystinosis patients16. Evidence supporting
the failure to degrade autophagy cargoes in primary PT Ctns−/−
cells include the following: abnormally elevated numbers of
mature autophagosomes under normal growth conditions; failure
to clear AVs formed after starvation-induced autophagy,
mimicking BfnA1 action; inability of BfnA1 to further induce the
LC3-II protein levels; and impaired degradation of the resting
AVs by a selective PI3K3/Vps34 inhibitor. In contrast, upstream
events regulating autophagosome biogenesis including
Atg7–Atg12 conjugation and phagophore formation were not
affected. Altogether, these data indicate that the functional loss of
cystinosin, causing lysosomal cystine storage, delays the autop-
hagy ﬂux, causing an accumulation of autophagosomes in vitro
and in vivo. Of note, the autophagy ﬂux was found to be fully
functional in ﬁbroblasts derived from Ctns mice39, in contrast
with the predictions based on the defective mTORC1 signaling in
cystinosis cells17. The reason for these discrepancies would
require further studies to understand the tissue and cell-speciﬁc
effects of cystinosin depletion.
The question remained how the lysosomal defect could impair
autophagy ﬂux and lead to epithelial dysfunction. A blockage of
the degradation of autophagic material may occur at any step
after autophagosome formation, due to factors regulating the
trafﬁcking of autophagosomes to lysosomes or the fusion between
both compartments. For instance, accumulation of LC3-positive
organelles unable to fuse with lysosomes has been observed
in many LSDs40. Accordingly, a potential cause for the impaired
autophagy ﬂux observed in cystinosis could be a delayed fusion
between lysosomes and autophagosomes. However, when
treating Ctns−/− cells with short incubations of BfnA1, which
accurately measure the autophagy ﬂux41, we observed a
substantial co-localization of LC3-positive vesicles with the
lysosome marker LAMP1, suggesting that the delivery and
autophagosome–lysosome fusion is not compromised in
cystinotic cells. Another indication is the perinuclear lysosomal
clustering in Ctns−/− cells; such centripetal movement of
lysosomes has been shown to mediate the autophagic degradation
of biomacromolecules20,42.
As the autophagy ﬂux also relies on the degradative capacity of
lysosomes11, an impaired lysosomal function may explain the
accumulation of autophagosomes in cystinosis cells. We postu-
lated that cystinosin deﬁciency may affect lysosome function
either by controlling the delivery of newly synthesized lysosomal
cathepsins from Golgi to the lysosome or by inhibiting the pro-
cessing/maturation of cathepsins within endolysosome compart-
ment. Our results support the latter hypothesis, evidencing an
impairment of lysosome proteolysis (observed both in vitro and
in vivo) as a result of defective cathepsin activation despite an
efﬁcient delivery of newly synthesized cathepsins from Golgi to
lysosomes. Furthermore, the rescue of lysosomal cystine
homeostasis through the transient expression of cystinosin in
Ctns−/− cells resulted in multi-level reactivation of the
autophagy–lysosome degradative pathways. Taken together, these
ﬁndings support a role of cystinosin—beyond its function in
cystine transport—in maintaining the lysosomal response to the
arrival of the autophagy cargoes, hence in cellular homeostasis.
The conjugation of impaired lysosomal dynamics and altered
lysosomal degradative capacity is strikingly similar to the cellular
changes resulting from the accumulation of monoclonal light
chains (κLCs) within endolysosomes of PT cells, causing a similar
epithelial dysfunction22. Furthermore, the uncontrolled increase
in lysosomal PtdIns(4,5)P2 that results from the loss-of-function
of the PtdIns(4,5)P2 5-phosphatase oculo cerebro renal Lowe
syndrome (OCRL), leads to lysosomal dysfunction and autop-
hagosome accumulation in PT cells from patients with Lowe
syndrome, another congenital disorder causing PT dysfunction
and RFS43. These data suggest that lysosomal accumulation of
cystine or speciﬁc κLCs or PtdIns(4,5)P2 may have similar
functional consequences on the epithelial phenotype, emphasiz-
ing the role of endolysosomes as crucial signaling hub to ensure
cellular homeostasis. As lysosomal acidiﬁcation is necessary for
the activation of cathepsins, one could speculate that the
vacuolar-type H+-ATPase (V-ATPase) complex might be altered
in absence of cystinosin44. Potential factors affecting V-ATPase
efﬁciency in LSD may include the following: storage of cholesterol
in the endolysosome membranes45; luminal oxidation of lysoso-
mal thiols by free cystine10; and accumulation of cystine sus-
taining mTORC1 activity and negatively regulating lysosome
biogenesis by suppressing TFE/MiTF signaling46,47. Recent stu-
dies showing that cystinosin is a member of the lysosomal
machinery that controls mTORC1 activity in vitro17, and that
overexpression of transcription factor EB (TFEB) stimulates
lysosomal cargo processing48 support the concept. Regardless of
the mechanism, impaired cellular clearance leads to accumulation
of autophagy substrates, such as dysfunctional mitochondria and
ubiquitinated proteins. Although autophagy deﬁcits have been
reported in LSDs37,38,49, the impact of lysosome–autophagy
defects on epithelial cell function remains unknown. Basal
autophagy operates to preserve the integrity of subcellular com-
partments, including damaged mitochondria50,51. Lack of
autophagy completion, due to impaired lysosomal degradation
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capacity or through inactivation of essential genes, leads to the
persistence of ubiquitinated proteins (including p62/SQSTM1)
and dysfunctional, ROS-producing mitochondria38. Our results
demonstrate the importance of this cellular quality-control
mechanism for the function of epithelial cells. Genetic or phar-
macologic blockage of basal autophagy resulted in accumulation
of ubiquitinated proteins and damaged/dysfunctional mitochon-
dria, leading to abnormal cell proliferation and apical dediffer-
entiation reﬂected by decreased uptake capacities. Similar to the
changes observed in autophagy-deﬁcient cells, there was a
remarkable accumulation of SQSTM1- and ubiquitin-forming
aggregates in Ctns−/− cells, with dysfunctional mitochondria
accumulating within enlarged, non-degradative lysosomes and
generating enhanced levels of mitochondrial ROS. These results
indicate the importance of maintaining a healthy mitochondria
repertoire to substantiate the solute transport activity in
PT cells52. In fact, primary mitochondrial diseases cause epithelial
transport defects and RFS4,52. Oculo Cerebro Renal Lowe
syndrome
The link between abnormal mitochondrial autophagy and
oxidative stress is well documented53,54, but how excessive
mitochondrial ROS production may cause epithelial cell dys-
function? Highly speciﬁc junctions modulate the epithelial phe-
notype along the renal tubule segments. The levels of the tight
junction adaptor protein ZO-1 and the localization of ZONAB, a
Y-box transcription factor that interacts with ZO-1, modulate the
switch from a proliferative to differentiated state in PT cells28. For
instance, the absence of the endosomal channel CFTR55 leads to
reduced ZO-1 stability, promoting nuclear translocation of
ZONAB and cell proliferation56. Similarly, shRNA-mediated
knockdown of Tjp1 encoding ZO-1 in primary PT cells triggers
an aberrant activation of tight junction-associated (ZONAB)
signaling, with subsequent induction of a phenotype switch
associating abnormal cell proliferation and dedifferentiation,
mimicking the epithelial dysfunction associated with cystinosis.
An abnormal activity of ZONAB has also been evidenced when
κLCs accumulate within dysfunctional endolysosomes22. Fur-
thermore, gain-of-function interventions targeting tight junction-
associated ZONAB signaling rescue epithelial differentiation and
reabsorptive capacity in cystinosis PT cells. Taken together, these
data suggest that the maintenance of tight junction integrity acts
an essential regulator of epithelial cell differentiation.
Recent advances have illuminated the understanding of reg-
ulatory mechanisms involved in tight junction architecture and
remodeling29–31. In particular, changes in the cellular rate of
Gα12/Src-mediated phosphorylation of ZO-1 associated with
oxidative stress may disrupt tight junctions and cause cell
damage29–31. In line with these observations, our results sub-
stantiate that the aberrant production of mitochondrial-ROS
enhances the Gα12/Src-mediated phosphorylation of ZO-1 and
its subsequent mistargeting to enlarged, non-degradative endo-
lysosomes. In turn, the loss of tight junction integrity promotes
ZONAB signaling and transcription of target genes that increase
cell proliferation and decrease differentiation27,28, resulting in
defective endocytosis in Ctns−/− cells. The relevance of this
abnormal cascade is supported by the gain- and loss-of-function
approaches targeting Gα12 or ZO-1/ZONAB, or by pharmaco-
logical interventions impeding activation of Gα12/Src signaling
axis in Ctns−/− PT cells and also in Ctns+/+ PT cells under
mitochondria-derived oxidative stress conditions (ROT or
blockade of autophagy). Consistent with this, treatment of Ctns
−/− mice and their derived mPTCs with mitochondrial-targeted
antioxidants, which are clinically tested in various mitochondrial
diseases57, not only repaired dysfunctional mitochondria and
averted mitochondrial oxidative stress, but also rescued the
integrity of tight junctions and the differentiation and endocytic
uptake capacity of the cells. These data extend the previous
ﬁndings showing that swan-neck deformities of PT segments58
could be delayed in Ctns-knockout mice by administrating
mitoquinone, an anti-oxidant compound that acts on
mitochondria.
In conclusion, we identify a novel link between lysosomal
storage and dysfunction, impaired autophagic clearance, and loss
of transport capacity in epithelial cells. These ﬁndings sub-
stantiate the role of endolysosome system in preserving the
autophagy-mediated quality control of mitochondria, which are
crucial for the high transport activities performed by specialized
epithelial cells. They also demonstrate the cross-talk between
mitochondria and tight-junction associated signal transduction
pathways regulating the epithelial phenotype. The effect of an
antioxidant compound speciﬁcally targeting mitochondria on the
function of Ctns−/− cells provides a promising approach to
alleviate the loss of vital metabolites in nephropathic cystinosis.
Methods
Antibodies and reagents. The following antibodies were used in this study: rat
anti-LAMP1 (sc-19992, Santa Cruz Biotechnology; 1:500); rabbit anti-LC3(PM036,
MBL; 1:100), rabbit anti-LC3 (NB100-2331, Novus Biologicals; 1:200), rabbit anti-
p62/SQSTM1 (PM045, MBL; 1:200); rabbit anti-GAPDH (2118, Cell Signaling
Technology; 1:10,000); mouse anti-β-actin (A2228, Sigma-Aldrich; 1:10,000); goat
anti-CtsD (sc-6486, Santa Cruz Biotechnology; 1:500); rabbit anti-GM130
(ab52649, Abcam; 1:500); mouse anti-Ubiquitin (sc-8017, Santa Cruz Biotechnol-
ogy; 1:1,000); mouse anti-PCNA (M0879, DAKO; 1:500); rabbit anti-Histone-3
(H3; ab4729, Abcam; 1:1,000); mouse anti-α-tubulin (T5168, Sigma-Aldrich;
1:1,000); rabbit anti-Prohibitin (ab28172, Abcam; 1:200); rabbit anti-ATG16L
(D6D5) (8089, Cell Signaling; 1:400); rabbit anti-ATG7 (A2856, Sigma-Aldrich;
1:200); mouse anti-BECN1 (sc-48341, Santa Cruz Biotechnology; 1:500); rat anti-
HA (11867423001, Roche; 1:500); rabbit anti-Calnexin (C4731, Sigma-Aldrich;
1:500); mouse anti-Phospho-Tyr-99 (PY99; sc-7020, Santa Cruz Biotechnology;
1:500); rabbit anti-ZO-1(sc-10804, Santa Cruz Biotechnology; 1:100); rabbit anti-
ZONAB (A303-070A, Bethyl Laboratories; 1:100); mouse anti-Gα12 (sc-515610,
Santa Cruz Biotechnology; 1:200); rabbit anti-phospho-Src Family (pTyr416; 6943,
Cell Signaling; 1:500), rabbit anti-Src (2109, Cell Signaling; 1:500); mouse
anti-PtdIns-3P (Z-P003, Echelon Biosciences; 1:200); rabbit anti-HO1 (ab13243,
Abcam; 1:500); rabbit anti-LCN2 (ab63929, Abcam; 1:200); and goat anti-green
ﬂuorescent protein (GFP) (AB0020-500, SICGEN; 1:500). Sheep anti-megalin
antibody (LRP2; 1:1,000) was kindly provided by P. Verroust and R. Kozyraki
(INSERM, Paris, France). Compounds included BfnA1 (ALX-380-030, Enzo Life
Sciences), PIK3C3/Vps34 inhibitor SAR-405 (A8883, APExBIO), autophagy
inhibitor Spautin-1 (S7888, Selleckchem.com), hydrogen peroxide (H2O2; H1009
Sigma-Aldrich), ROT (R8875, Sigma-Aldrich), SU6656 (s9692, Sigma-Aldrich),
and Mito-TEMPO (MT; ALX-430-150-M005, Enzo Life Sciences).
Generation and maintenance of ctns zebraﬁsh. ctns-speciﬁc left and right
TALENs (ctns-TALENs) were constructed in according to Golden Gate TALEN
assembly protocol and using the Golden Gate TALEN and TAL Effector Kit 2.0
(Addgene, Kit 1000000024). CIscript-GoldyTALEN was a gift from Daniel Carlson
& Stephen Ekker (Addgene, plasmid 38142). TALENs were designed with the TAL
Effector Nucleotide Targeter 2.0 software on the Website of Cornell University.
The TALENs target the exon 3 of ctns zebraﬁsh gene: left TALEN-F: 5′-TCTTT
TAATCCTTTGTGTTCACA-3′ and right TALEN-R: 5′-CATCTGTAACGGTTTA
TTTCAAT-3′.
The spacer between two TALEN target sites is ~ 15 nucleotides and contains an
AciI restriction site in the middle, which is used for mutant screening. The TALEN
expression plasmids were linearized with BamHI and then used for in vitro
transcription (mMESSAGE mMACHINE T3 kit, Ambion). Approximately 1 nl of
TALEN mRNAs (400 ng µl) was injected into one-cell stage zebraﬁsh (Danio rerio)
embryos. After 24 h, genomic DNA was extracted from injected embryos with
normal appearance. Targeted genomic loci were ampliﬁed by using primers
designed to anneal ~ 240 base pairs and mutant allele was detected by AciI
digestion of PCR product. The TALEN-injected embryos were raised to adulthood
(F0) and outcrossed with wild-type zebraﬁsh. The embryos were then raised to
adulthood (F1) for screening of heterozygous carriers. We identiﬁed a heterozygous
carrier harboring ctns +/del8 mutation and (F1) generations were crossed for
obtaining homozygous mutant carrying ctnsdel8/del8. Zebraﬁsh were kept at day/
night cycle of 14/10 h at 28 °C. Zebraﬁsh embryos were obtained through natural
spawning in the facility of the University of Zurich and raised in E3 medium
containing 0.01% methylene blue and prepared for analyses. Adult zebraﬁsh were
maintained in the zebraﬁsh facility of Hubrecht Institute (Utrecht, The
Netherlands). Zebraﬁsh were killed by immersion in system water containing 300
µg ml−1 tricaine methane sulfonate (MS222). The experiments performed on adult
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ﬁsh (Hubrecht Institute) were approved by the Animal Care and Use Committee of
the Royal Netherlands Academy of Arts and Sciences.
Rescue experiments in ctns zebraﬁsh. The plasmids containing wild type or
mutant (ΔDVVF346-349) human CTNS compleentary DNA were kindly provided
by C. Antignac (INSERM, Paris, France). The T3 promoter sequence was cloned
into the XhoI restriction site of the enhanced GFP vector by using forward primer:
5′-TCGAGGATCCATTAACCCTCACTAAAGGGAAC-3′ and reverse primer: 5′-
TCGAGTTCCCTTTAGTGAGGGTTAATGGATCC-3′. Either wild type or
mutant CTNS mRNA was synthesized by using the mMESSAGE mMACHINE T3
transcription Kit (Invitrogen). The microinjection of either wild type or mutant
CTNS mRNA was performed in ctns del8/del8 zebraﬁsh embryos at one-cell stage
and subsequently collected at 5 dpf for cystine measurements. Where indicated, a
working solution of cysteamine at 1 mM was prepared by diluting the stock
solution within E3 medium. After dechorionation, ctns zebraﬁsh larvae at 2 dpf
were incubated in the E3 medium in the presence or in the absence of cysteamine
until to the sampled day (5 dpf), and the zebraﬁsh medium was renewed daily.
Twenty zebraﬁsh embryos per group were pooled and homogenized by sonication,
and prepared for cystine measurements.
Mouse model. Experiments were conducted on age- and gender-matched Ctns−/−
and Ctns+/+ littermates (C57BL/6 background8,9). Mice were maintained under
temperature-and humidity-controlled conditions with 12 h light/12 h dark cycles
with free access to appropriate standard diet in accordance with the institutional
guidelines of National Institutes of Health Guide for the Care and Use of
Laboratory Animals.
Mice aged 16 weeks were treated by daily intraperitoneal injection of Mito-
TEMPO (1mg kg−1 body weight in NaCl 0.9%) or vehicle (NaCl 0.9%) (n = 4 for
each group), and killed after 30 days. Kidney tissues and/or urines were collected
for analyses. The mouse study protocols (University of Zurich) were approved by
the local legal authority (Veterinary Ofﬁce, Canton of Zurich, Switzerland).
Renal function. The mice were placed overnight in metabolic cages with ad libitum
access to food and drinking water; urine was collected over ice9,22. The urine
parameters were measured using a UniCel DxC 800 pro Synchron (Beckman
Coulter, Fullerton, CA, USA), whereas Clara cell protein (CC16) concentration was
measured in duplicate by enzyme-linked immunosorbent assay (BIOMATIK
EKU03200).
Kidney isolation and primary cultures of mouse PT cells. The kidneys were
collected from Ctns+/+ and Ctns−/− mice: one kidney was split transversally and
one half was ﬁxed and processed for immunostaining, whereas the other half was
ﬂash frozen, homogenized by Dounce homogenizer in 1 ml of RIPA buffer that
contains protease and phosphatase inhibitors, and processed for western blot
analysis9,22. The contralateral kidney was taken to generate primary cultures of
mPTCs22. Freshly micro-dissected PT segments were seeded onto collagen-coated
chamber slides (C7182, Sigma-Aldrich) and/or collagen-coated 6- or 24-well plates
(145380 or 142475, Thermo Fisher Scientiﬁc), and cultured at 37 °C and 5% CO2 in
Dulbecco’s modiﬁed Eagle’s medium/F12 (21041-025, Thermo Fisher Scientiﬁc)
with 0.5% dialyzed fetal bovine serum (FBS), 15 mM HEPES (H0887, Sigma-
Aldrich), 0.55 mM sodium pyruvate (P2256, Sigma-Aldrich), 0.1 ml l−1 non-
essential amino acids (M7145, Sigma-Aldrich), hydrocortisone, human epidermal
growth factor, epinephrine, insulin, triiodothyronine, transferrin (TF), and genta-
micin/amphotericin (Single Quots kit, CC-4127, Lonza), pH 7.40, 325 mOsm kg−1.
The medium was replaced every 48 h. Conﬂuent monolayers of mPTCs were
expanded from the tubular fragments after 6–7 days, characterized by a high
endocytic uptake capacity. These cells were mycoplasma free. All experiments were
performed on conﬂuent monolayers grown on chamber slides or plates.
Starvation of primary PT cells and treatments. Serum and amino acid removal
was performed by washing mPTCs with Hank’s balanced salt solution (55021 C,
Sigma-Aldrich) and placing them in nutrient-deprived medium. Where indicated,
autophagy was inhibited by addition of either PIK3C3/Vps34 inhibitor SAR-405 (5
μM in cell culture medium for 16 h, unless otherwise speciﬁed59) or Spautin-1 (25
μM in cell culture medium for 16 h60). Lysosomal proteolysis was inhibited by
addition of BfnA1 (250 nM for 4 h, unless otherwise stated). Where indicated,
oxidative stress was triggered by treating mPTCs with either hydrogen peroxide
(0.5 mM for 1 h) or with ROT (250 nM for 8 h). Where indicated, mPTCs were
treated with either the mitochondria-targeted oxidant scavenger Mito-TEMPO (10
μM in culture medium for 12 h, Enzo Life Sciences) or with a selective Src-family
kinase inhibitor SU6656 (5 μM in culture medium for 12 h, Sigma Aldrich).
Afterwards, the cells were processed and analyzed as described below.
Adenovirus transduction in primary PT cells. For RNA interference studies, the
adenovirus constructs include scrambled short hairpin or shRNAs encoding
individually mouse Atg7 or encoding mouse Ybx3/Csda, or encoding mouse Gna12
or encoding mouse Tjp1. For expression studies, adenovirus constructs include
cytomegalovirus (Null) or particles individually carrying mouse GFP-tagged-
Map1lc3b or carrying mouse red ﬂuorescent protein (RFP)/2 × FLAG tagged-
Lamp1 or carrying GFP tagged-Csda or carrying human HA-tagged-TJP1 or
carrying mouse HA-tagged-Ctns. The aforementioned adenovirus constructs were
purchased from Vector Biolabs (University City Science Center, Philadelphia,
USA).
The primary mouse PT cells were plated onto collagen-coated chamber slides or
24-well or 6-well tissue culture plates. Adenovirus transduction was performed 24 h
after plating when the cells reached ~ 70–80% conﬂuence. The cells were
subsequently incubated for 16 h at 37 °C with culture medium containing the virus
at the concentration (0.2125 × 109 PFUml−1). The cells were afterwards challenged
with fresh medium every 2 days, cultured for 5 days (unless otherwise speciﬁed),
and collected for analyses.
Quantitative real-time PCR. Total RNA was extracted from mouse and zebraﬁsh
kidney tissues using Aurum Total RNA Fatty and Fibrous Tissue Kit (Bio-Rad,
Hercules, CA). DNAse I treatment was performed to eliminate genomic DNA
contamination. Total RNA was extracted from primary cell cultures with RNA-
queous kit (Applied Biosystems, Life Technologies). One microgram of RNA was
used to perform the reverse transcriptase reaction with iScript cDNA Synthesis Kit
(Bio-Rad). Changes in mRNA levels of the target genes were determined by relative
reverse transcriptase-quantitative PCR with a CFX96 Real-Time PCR Detection
System (Bio-Rad) using iQ SYBR Green Supermix (Bio-Rad). The analyses were
performed in duplicate with 100 nM of both sense and anti-sense primers in a ﬁnal
volume of 20 µl using iQ SYBR Green Supermix (Bio-Rad). Speciﬁc primers were
designed using Primer3 (Supplementary Table 1 and 2). PCR conditions were 95 °C
for 3 min followed by 40 cycles of 15 s at 95 °C, 30 s at 60 °C. The PCR products
were sequenced with the BigDye terminator kit (Perkin Elmer Applied Biosystems)
using ABI3100 capillary sequencer (Perkin Elmer Applied Biosystems). The efﬁ-
ciency of each set of primers was determined by dilution curves (Supplementary
Table 1 and 2). The program geNorm version 3.4 was applied to characterize the
expression stability of the candidate reference genes in kidneys and six reference
genes were selected to calculate the normalization factor61. The relative changes in
targeted genes over Gapdh mRNAs were calculated using the 2−ΔΔCt formula.
Endocytosis assay. The endocytic uptake was monitored in mPTCs cells following
incubation for 60 min at 4 °C with 50 μg ml−1 bovine serum albumin (BSA)–Alexa-
Fluor-647 (A34785, Thermo Fisher Scientiﬁc) or with 50 μg ml−1 BSA–Alexa-
Fluor-488 (A13100, Thermo Fisher Scientiﬁc) in complete HEPES-buffered Dul-
becco’s modiﬁed Eagle’s medium. The cells were given an acid wash and warmed to
37 °C in growth cell medium for 15 min before being ﬁxed and processed for
immunoﬂuorescence analyses22.
Lysosomal activity. The detection of lysosomal activity was performed in live
mPTCs using Bodipy-FL-PepA (P12271, Thermo Fischer Scientiﬁc) or Magic Red-
(RR)2 substrate (MR-CtsB; 938, Immunochemistry Technologies) according to the
manufacturer’s speciﬁcations. The cells were pulsed with 1 μM Bodipy-FL-
Pepstatin A or with 1 μM Magic Red-(RR)2 in Live Cell Imaging (A14291DJ,
Thermo Fischer Scientiﬁc) medium for 1 h at 37 °C followed by ﬁxation and
immunostaining with anti-LAMP1 or anti-HA antibody, and subsequently ana-
lyzed by confocal microscopy22.
The lysosome-based processing was measured in zebraﬁsh embryos using
bovine β-lactoglobulin (Sigma-Aldrich). β-Lactoglobulin was tagged with Cy5
using TM2 Ab labeling kit (Amersham) in accordance with the manufacturer’s
instructions. After anesthesia (0.2 mg ml−1 tricaine (3-amino benzoic acid ethyl
ester, Sigma-Aldrich), cdh17::GFP-expressing ctns zebraﬁsh embryos were injected
at 5 dpf with Cy5-β-lactoglobulin (5 μg μl−1) via the common cardinal vein. Tracer
injection into larvae blood was validated by monitoring the ﬂuorescent vessels after
injection. Larvae were incubated in fresh E3 medium for 20 or 120 min and
subsequently ﬁxed overnight in 2% paraformaldehyde (PFA)/phosphate-buffered
saline (PBS) containing 0.1% Tween-20, and analyzed by ﬂuorescent microscope
(Zeiss, Germany).The ﬂuorescence intensities and the numbers of β-lactoglobulin+
structures were quantiﬁed by using cell image analysis software Imaris (Bitplane).
Extracellular ﬂux analysis and metabolic measurement. OCR was measured in
XFp Extracellular Flux Analyzers (Agilent Seahorse Biosciences) in mPTCs incu-
bated with XF-Base Medium (non-buffered RPMI 1640 containing either 2 mM L-
glutamine, 1 mM sodium pyruvate and 10 mM glucose, pH 7.4). Three measure-
ments were assessed under basal conditions and upon addition of 2 μM Oligo-
mycin (Oligo), 0.5 μM FCCP, and 1 μM ROT/Antimycin-A (ANT). All the
reagents were provided by XFp Cell Mito Stress Test Kit (Agilent Seahorse Bios-
ciences). OCR measurements were normalized to the numbers of the cells (TC10
automated cell counter, Bio-Rad).
Mitochondrial membrane potential measurement. The mitochondrial mem-
brane potential (Δψ) was measured in according with the manufacturer’s speciﬁ-
cations. The cells were pulsed with 50 nM TMRM perchlorate (T668 Thermo
Fisher Scientiﬁc) for 30 min in live-cell imaging at 37 °C. After washing, the cells
were subsequently analysed by confocal microscopy62. The ﬂuorescence intensity
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was quantiﬁed by using the open-source cell image analysis software CellProﬁler63
as described below.
ROS detection. The cells were pulsed with 5 µM CellROX Green Reagent (C10444,
Thermo Fisher Scientiﬁc) or with 2.5 μM MitoSOX Red Mitochondrial Superoxide
Indicator (M36008, Thermo Fisher Scientiﬁc) for 10 min in live-cell imaging at 37 °
C. After washing, the cells were subsequently analysed by confocal microscopy62.
The ﬂuorescence intensity was quantiﬁed by using the open-source cell image
analysis software CellProﬁler63 as described below.
Immunoﬂuorescence and confocal microscopy. Fresh mouse kidneys were ﬁxed
by perfusion with 50–60 ml of 4% PFA in PBS (158127, Sigma-Aldrich), dehy-
drated and embedded in parafﬁn at 58 C°. Parafﬁn blocks were sectioned into
consecutive 5 μm-thick slices with a Leica RM2255 rotary microtome (Thermo
Fisher Scientiﬁc) on Superfrost Plus glass slides (Thermo Fisher Scientiﬁc). Before
staining, slides were deparafﬁnized in changes of CitriSolv (22-143-975, Thermo
Fisher Scientiﬁc) and 70% isopropanol. Antigen retrieval was accomplished by
incubating in sodium citrate buffer (1.8% 0.1 M citric acid, 8.2% 0.1 M sodium
citrate, in distillated water, pH 6.0) in a rice cooker for 30 min. The slides were
quenched with 50 mM NH4Cl, blocked with 0.5% BSA in PBS Ca/Mg (D1283,
Sigma-Aldrich) for 30 min and stained with primary antibodies speciﬁc for PCNA,
LRP2, LC3, and SQSTM1 diluted in blocking buffer overnight at 4 °C. After two
washes in 0.1% Tween 20 (v/v in PBS), the slides were incubated with the corre-
sponding ﬂuorophore-conjugated Alexa secondary antibodies (Invitrogen) diluted
in blocking buffer at room temperature for 1 h and counterstained with 1 μg
Biotinylated Lotus Tetragonolobus Lectin (LTL; B-1325 Vector Laboratories) and
1 µM 4’,6-diamino-2-phenylindole dihydrochloride (DAPI; D1306, Thermo
Fischer Scientiﬁc). The slides were mounted in Prolong Gold Anti-fade reagent
(P36930, Thermo Fisher Scientiﬁc), acquired on Leica SP8 confocal laser scanning
microscope (Center for Microscopy and Image Analysis, University of Zurich)
equipped with a Leica APO × 63 NA 1.4 oil-immersion objective at a deﬁnition of
1,024 × 1,024 pixels (average of 8 or 16 scans), adjusting the pinhole diameter to 1
Airy unit for each emission channel to have all of the intensity values between 1
and 254 (linear range). The micrographs were processed with Adobe Photoshop
(version CS5, Adobe System, Inc., San Jose, USA) software. Quantitative image
analysis was performed by selecting randomly ∼ 5 visual ﬁelds per each slide that
included at least three to ﬁve PTs (LTL positive), using the same setting parameters
(i.e., pinhole, laser power, and offset gain and detector ampliﬁcation below pixel
saturation). The numbers of LC3or SQSTM1-positive structures per PT (marked
by LTL) were counted by using the open-source cell image analysis software
CellProﬁler63.
The mPTCs were ﬁxed for 10 min with 4% PFA in PBS, quenched with 50 mM
NH4Cl, and permeabilized for 20 min in blocking buffer solution containing 0.1%
Triton X-100 and 0.5% BSA dissolved in PBS. Subsequently, mPTCs were
incubated overnight with the appropriate primary antibodies at 4 °C. After repeated
washing with PBS, the slides were incubated for 45 min with the suitable
ﬂuorophore-conjugated Alexa secondary antibodies (Invitrogen), counterstained
with 1 µM DAPI for 5 min, mounted with the Prolong Gold Anti-fade reagent, and
analyzed by a Leica SP8 confocal laser scanning microscope (Center for
Microscopy and Image Analysis, University of Zurich) using the settings described
above. Quantitative image analysis was performed by selecting randomly ﬁve visual
ﬁelds pooled from biological triplicates, with each ﬁeld including at least 20–25
cells, using the same setting parameters (i.e., pinhole, laser power, and offset gain
and detector ampliﬁcation below pixel saturation). The 3D reconstructions of
LAMP1-positive vesicles were generated in Imaris software using full confocal
z-stacks (around 20) of each cell. The quantitative cell image analyses were
performed using the open-source cell image analysis software CellProﬁler63. In
particular, the speciﬁc module “Measure-Object-Intensity-Distribution” was used
to score the number and the vesicle size of LAMP1 or CtsD-positive structures and
the fractions of LAMP1-positive structures contained into perinuclear region (area
within 10 μm of the nucleus) and peripheral region (area ≥ 15 μm from the
nucleus), respectively. The pipeline “Speckle counting” was used to identify smaller
objects (LC3 or SQSTM1, or Prohibitin or BSA, or CtsD or MR-Ctsb, or ATG16L-
positive structures) surrounding larger objects and to perform per-object aggregate
measurements. The pipeline “Cell/particle counting and scoring the percentage of
stained objects” was used to score either the numbers of LAMP1+ vesicles
containing LC3+ autophagosomes or PepA, or CtsD + vesicles or tight junction-
ZO-1+ structures, or Prohibitin+ mitochondria, or the numbers of CtsD+ vesicles
containing MR-CtsB peptides or Golgi protein GM130. The “Cytoplasm–Nucleus
Translocation Assay” was used to score the numbers of ZONAB or BrdU or
PCNA-positive nuclei.
EM and tomography. Zebraﬁsh larvae and cultured mPTCs were ﬁxed in 2% PFA/
2.5% glutaraldehyde (for zebraﬁsh) and 4% PFA/0.1% glutaraldehyde (for cells) in
100 nM sodium cacodylate, at pH 7.43, dehydrated, and embedded in LR-White
resin (LADD Research Industries). The grids were viewed on a Philips CM100
transmission electron microscope at 80 kV. Autophagic vacuoles were identiﬁed
and categorized as autophagosomes or autophagolysosomes according to standard
criteria23. The term autophagic vacuole was used when the differentiation between
autophagosome and autophagolysosomes was not possible. The number of
autophagic vacuoles was determined by using i-TEM software (Olympus, Ger-
many). For electron tomography, 200–250 nm-thick sections were collected on
formvar-coated copper slot grids using a Leica EM UC7 ultramicrotome (Leica
Microsystem GmbH, Vienna, Austria). Colloidal gold particles (10 nm) were
applied as ﬁducials on both surfaces of the grids and the samples were imaged on a
200 kV Tecnai G2 20 electron microscope (FEI, Eindhoven) at a magniﬁcation of ×
11,500, resulting in pixel sizes of 1.95 nm. Single, tilted image series (± 60°
according to a Saxton scheme with the initial tilt step of 2°) were acquired using
Xplorer3D (FEI) with an Eagle 2,048 × 2,048 CCD camera (FEI). Tilted series
alignment, tomographic reconstructions, image segmentation, and visualization
were done with the IMOD software package.
Correlative light EM. The cells were grown on ﬁnder grids and prepared for
confocal microscopy analyses. Z-stacks of cells of interest were taken with the
PerkinElmer UltraView ERS confocal microscope. The coordinates of the cells on
the ﬁnder grid were determined by bright-ﬁeld microscopy. Cells were ﬁxed in 1%
glutaraldehyde in 0.1 M cacodylate buffer (Sigma) and post-ﬁxed with 1.5%
potassium ferricyanide, 1% OsO4 in 0.1 M cacodylate buffer. Cells were stained
overnight with 0.5% uranyl acetate, dehydrated in ethanol, and embedded in epon.
After baking for 48 h at 60 °C, the resin was released from the glass coverslip by
temperature shock in liquid nitrogen. Serial sections (70–90 nm) were collected on
carbon-coated formvar slot grids and imaged with a Zeiss LEO 512 electron
microscope. Images were acquired by a 2k × 2k bottom-mounted slow-scan
Proscan camera controlled by EsivisionPro 3.2 software.
Soluble and insoluble fractionation. The cells were lysed in buffer containing 50
mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1% sodium-
deoxycholate supplemented with protease and phosphatase inhibitors, and cen-
trifuged at 16,000 r.p.m. at 4 °C for 20 min, to collect the soluble fraction
(supernatant). The pellet was suspended in a buffer containing 4% SDS and 20 mM
HEPES, pH 7.5, protease and phosphatase inhibitors, and further centrifuged at
18,000 r.p.m. at room temperature for 10 min, to collect the insoluble fraction
(supernatant). The samples were boiled at 95 °C for 5 min and analyzed by western
blotting.
Immunoprecipitation. The cells were lysed in a buffer containing 25 mM Tris/HCl
adjusted to pH 7.4, 150 mM NaCl, 1% NP-40, and 1 mM EDTA, 5% glycerol,
protease and phosphatase inhibitors for 10 min at 4 °C. Lysates were centrifuged at
12,000 r.p.m. for 10 min and the supernatants were incubated with 1.5 μg of pri-
mary anti-ZO-1 antibody for 16 h at 4 °C. After addition of 50 μl of protein A
sepharose beads (P9424, Sigma), lysates were incubated at 4 °C for 12 h with gentle
shaking. Agarose beads were washed for three times and then collected through
centrifugation at 4,000 r.p.m. for 1 min. Beads were reduced by the addition of 35 μl
of Laemmli sample buffer, heated at 95 °C for 5 min, and resolved on 10% SDS-
polyacrylamide gel electrophoresis (PAGE) gel, and analyzed by western blotting.
Western blotting. Proteins were extracted from mouse or zebraﬁsh kidney tissues
or primary cultured cells, lysed using a buffer, which contains protease
(1836153001, Roche) and phosphatase inhibitors (04906845001, PhosSTOP
Sigma), followed by sonication and centrifugation at 12,000 r.p.m. for 10 min at 4 °
C. The samples were thawed on ice, normalized for protein (20 μg per lane),
dissolved in Laemmli sample buffer, and separated by SDS-PAGE under reducing
conditions. After blotting onto polyvinylidene diﬂuoride and blocking with 5%
non-fat milk (1706404, Bio-Rad Laboratories) diluted in PBS, the membranes were
incubated overnight at 4 °C with primary antibody, washed, incubated with
peroxidase-labeled secondary antibody, and visualized with enhanced chemilumi-
nescence (WBKLS0050, Millipore, Life technologies). For re-probing, the mem-
branes were rinsed, incubated for 30 min at 55 °C in a stripping buffer (62.5 mmol l
−1 Tris-HCl, 2% SDS, 100 mM mercaptoethanol, adjusted to pH 7.4), before
incubation with primary antibodies. Quantitative analyses were performed by
scanning the blots and measuring the relative density of each band normalized to
β-actin, GAPDH, or α-tubulin with ImageJ software. Unprocessed scans of original
blots are shown in Supplementary Fig. 13.
Proximity ligation assay. The PLA assay was performed using the Duolink in situ
reagents (Olink Biosciences) in according with the manufacturer’s speciﬁcations.
The cells were ﬁxed with 4% PFA in PBS for 15 min at room temperature. After
blocking with 0.1% Triton X-100 and 0.5% BSA dissolved in PBS, the cells were
incubated overnight at 4 °C with primary antibodies. Following incubation with
Duolink PLA anti-rabbit Plus and anti-mouse Minus probes (1:5 dilution, Olink
Bioscience) at 37 °C for 1 h, ligation, rolling circle ampliﬁcation, and detection were
performed using the Duolink In Situ Detection Reagents Red (Olink Bioscience).
Nuclei were counterstained with DAPI. PLA signals were documented by a Leica
SP8 confocal microscope and quantiﬁed by using cell image analysis software
CellProﬁler63.
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PtdIns-3P detection. The cells were ﬁxed with 2% formaldehyde in PBS for 15
min at room temperature. After washing with PBS containing 50 mM NH4Cl, the
cells were permeabilized for 5 min by the addition of 20 μM digitonin in bufferA
(20 mM Pipes pH 6.8, 137 mM NaCl, 2.7 mM KCl). Digitonin was removed by
three rinses in bufferA and cells were blocked for 45 min with buffer A supple-
mented with 5% (v/v) FBS and 50 mM NH4Cl. Monoclonal mouse anti-PtdIns-3-P
antibody64 was diluted in buffer with 5% FBS for 1 h (1:300). After washing with
buffer A for three times, anti-mouse IgG secondary antibodies were applied in
buffer with 5% FBS (1:400) for 30 min. Cells were underwent to post ﬁxation for 5
min in 2% PFA, washed with PBS containing 50 mM NH4Cl, and then mounted
with the Prolong Gold Anti-fade reagent. PtdIns-3-P levels were analyzed by using
a Leica SP8 confocal laser scanning microscope and quantiﬁed by using
CellProﬁler63.
Proliferation assay. To measure cell proliferation, the cells were seeded in 24-well
plates at a density of 2.0 × 104 cells per well. The cells were cultured for 3 days and
cell medium was renewed daily. Afterwards, the cells were trypsinized every 24 h
and quantiﬁed using the Countess automated cell counter TC10 automated cell
counter (BIO-RAD). The time-course experiments were repeated three times using
cells derived from three individual mice per each group. Where indicated, cells
were incubated with BrdU (1.5 μg ml−1; Sigma-Aldrich) in accordance with the
manufacturer’s protocol. BrdU-labeled cells were detected by immunostaining
using rat anti-BrdU antibody (Oxford Biotechnology; 1:500), followed by the
speciﬁc secondary biotinylated goat anti-rat antibody (1:300; Jackson Immunor-
esearch) and mounted with the Prolong Gold Anti-fade reagent. The slides were
analyzed by using a Leica SP8 confocal laser scanning microscope and quantiﬁed
by using CellProﬁler.
Cystine measurement. Kidney tissues from mice kidney tissue or from zebraﬁsh
embryos, or primary cultured cells were homogenized and lysed with N-
ethylmaleimide (NEM) solution containing 5.2 mmol l−1 N-ethylmaleide in 10
mmol l−1 potassium phosphate buffer adjusted to pH 7.4. The lysates were collected
and precipitated with sulfosalicylic acid (12% w/v) and centrifuged at 10,000 r.p.m.
for 10 min at 10 °C. The resulting supernatant was dissolved in citrate loading
buffer (Biochrom Ltd, Cambridge, UK) and 50 µl of this solution was analyzed by
Biochrom 30 Plus Amino Acid Analyzer (Biochrom Ltd). The protein pellet was
dissolved in 0.1 mol l−1 NaOH solution and the protein concentration was deter-
mined by Biuret method. The concentration of amino acids was measured by using
a lithium high performance physiological column (Biochrom) followed by post-
column derivatization with ninhydrin. The amino acids were identiﬁed according
to the retention time and the ratio of the area between the two wavelengths (570
nm and 440 nm) and quantiﬁed by using EZChrom Elite software (Agilent
Technologies Inc., Pleasanton, California, USA). Cystine concentration was nor-
malized to the protein concentration and reported in nmol per mg protein. N-
ethylmaleimide
Data analysis and statistics. The quantitative data were expressed as means±
SEM. Differences between experimental groups were evaluated using one-way
analysis of variance followed by Bonferroni or Dunnet’s post hoc test, when
appropriate. When only two groups were compared, unpaired or paired two-tailed
Student’s t-tests were used as appropriate. No statistical methods were used to
predetermine the sample size. We estimated the sample size considering the var-
iation and mean of the samples. Assumptions for statistical analyses were met (that
is, normal distribution and equal variance). The sample size (number of cells or
number of biological replicates derived from distinct mice or zebraﬁsh) of each
experimental group is described in ﬁgure legends. The results are representative of
at least three independent experiments, unless speciﬁed in the ﬁgure legends. None
of the samples/animals was excluded from the experiment, and the animals were
not randomized. The investigators were not blinded to allocation during the
experiments and outcome assessment. GraphPad Prism software was used for all
statistical analyses. Statistical signiﬁcance was set at a P< 0.05.
Data availability statement. The data that support the ﬁndings of this study are
available on reasonable request from the corresponding authors (O.D. and A.L.)
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